Analysis of clinical outcomes after hospitalization for acute coronary syndrome in GLP-1 drug users vs non-users evaluates whether prior GLP-1 therapy improves post-heart attack recovery.
Key findingAnalysis of clinical outcomes after hospitalization for acute coronary syndrome in GLP-1 drug users
What the researchers found
Analysis of clinical outcomes after hospitalization for acute coronary syndrome in GLP-1 drug users vs non-users evaluates whether prior GLP-1 therapy improves post-heart attack recovery.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Clinical Outcomes After Hospitalization for Acute Coronary Syndrome in Patients Treated with Semaglutide Versus Bariatric Surgery: A Retrospective Multicenter Analysis.
HCA healthcare journal of medicine, 6(3), 249-257
Citation
Ascandar, Nameer; Boadu, Charles; Stepman, Gauthier; Skaf, George; Oyesanmi, Olugbenga; Omar, Sabry; Ali, Rias; Schandorf-Lartey, Michael. (2025). Clinical Outcomes After Hospitalization for Acute Coronary Syndrome in Patients Treated with Semaglutide Versus Bariatric Surgery: A Retrospective Multicenter Analysis.. HCA healthcare journal of medicine, 6(3), 249-257. https://doi.org/10.36518/2689-0216.1960